Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.

International Wound Journal
Lawrence A DiDomenicoCharles M Zelen

Abstract

Amnion and chorion allografts have shown great promise in healing diabetic foot ulcers (DFUs). Results from an interim analysis of 40 patients have demonstrated the accelerated healing ability of a novel aseptically processed, dehydrated human amnion and chorion allograft (dHACA). The goal of this study was to report on the full trial results of 80 patients where dHACA was compared with standard of care (SOC) in achieving wound closure in non-healing DFUs. After a 2-week screening period, during which patients with DFUs were unsuccessfully treated with SOC, patients were randomised to either SOC alone or SOC with dHACA applied weekly for up to 12 weeks. At 12 weeks, 85% (34/40) of the dHACA-treated DFUs healed, compared with 33% (13/40) treated with SOC alone. Mean time to heal within 12 weeks was significantly faster for the dHACA- treated group compared with SOC, 37 days vs 67 days in the SOC group (P = .000006). Mean number of grafts used per healed wound during the same time period was 4.0, and mean cost of the tissue to heal a DFU was $1771. The authors concluded that aseptically processed dHACA heals DFUs significantly faster than SOC at 12 weeks.

References

May 27, 2003·Diabetes Care·William A MarstonUNKNOWN Dermagraft Diabetic Foot Ulcer Study Group
Jun 9, 2005·Advances in Skin & Wound Care·Jeffrey A NiezgodaJason P Hodde
May 1, 2008·European Cells & Materials·Hassan NiknejadAlexander M Seifalian
Mar 30, 2010·Journal of Clinical Epidemiology·David MoherUNKNOWN Consolidated Standards of Reporting Trials Group
Oct 16, 2013·Journal of Vascular Surgery·Joseph L MillsUNKNOWN Society for Vascular Surgery Lower Extremity Guidelines Committee
Aug 25, 2015·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Vickie R DriverKevin C Chung
Oct 18, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·J W WalshD J Margolis
Nov 9, 2016·Plastic and Reconstructive Surgery. Global Open·Lawrence A DiDomenicoCharles M Zelen
Jun 15, 2017·The New England Journal of Medicine·David G ArmstrongSicco A Bus
Jan 7, 2018·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Samuel R NussbaumDonna Cartwright

❮ Previous
Next ❯

Citations

Apr 10, 2019·Current Vascular Pharmacology·F J Álvaro-AfonsoN Papanas
Apr 25, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Behrouz FarhadihosseinabadiHassan Niknejad
Jul 28, 2020·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Wentao HuangWencan Xu
Feb 23, 2020·Current Reviews in Musculoskeletal Medicine·Hailey P HuddlestonAdam B Yanke
Apr 20, 2021·Journal of the American Podiatric Medical Association·Andrew S AuJames W Stavosky

❮ Previous
Next ❯

Software Mentioned

PASW

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.